{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:58:42Z","timestamp":1648871922696},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.neurol.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T17:15:26Z","timestamp":1321290926000},"page":"181-186","source":"Crossref","is-referenced-by-count":0,"title":["Accident vasculaire c\u00e9r\u00e9bral isch\u00e9mique et corn\u00e9e verticill\u00e9e r\u00e9v\u00e9lant une maladie de Fabry chez une femme"],"prefix":"10.1016","volume":"168","author":[{"given":"D.","family":"Fetter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bagan-Triquenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Guegan-Massardier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Guyant-Marechal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hannequin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neurol.2011.03.013_bib0005","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alpha treatment","volume":"34","author":"Beck","year":"2004","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.neurol.2011.03.013_bib0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry disease: impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2011.03.013_bib0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/S1516-31801994000400007","article-title":"Fabry's disease in a female carrier with bilateral thalamic infarcts: a case report and a family study","volume":"112","author":"Castro","year":"1994","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"10.1016\/j.neurol.2011.03.013_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2011.03.013_bib0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry outcome survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.neurol.2011.03.013_bib0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/01.wnl.0000338566.54190.8a","article-title":"Diagnostic utility of different MRI and MR angiography measures in Fabry disease","volume":"72","author":"Fellgiebel","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2011.03.013_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1017\/S0317167100002936","article-title":"Fabry's disease presenting as stroke in a young female","volume":"31","author":"Giacomini","year":"2004","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"10.1016\/j.neurol.2011.03.013_bib0040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","article-title":"Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy","volume":"62","author":"Hilz","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2011.03.013_bib0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral auto-regulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2011.03.013_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-510X(89)90113-5","article-title":"Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease","volume":"90","author":"Hozumi","year":"1989","journal-title":"J Neurol Sci"},{"issue":"3B","key":"10.1016\/j.neurol.2011.03.013_bib0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S0004-282X2006000500002","article-title":"White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up","volume":"64","author":"Jardim","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.neurol.2011.03.013_bib0060","doi-asserted-by":"crossref","unstructured":"Labauge P. G\u00e9n\u00e9tique et maladies de la substance blanche. EMC (Elsevier Masson SAS, Paris), Neurologie 2009;17-001-A-50.","DOI":"10.1016\/S0246-0378(09)50908-6"},{"key":"10.1016\/j.neurol.2011.03.013_bib0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366\u00a0patients in the Fabry outcome survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.neurol.2011.03.013_bib0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000059897","article-title":"Kidney involvement in Anderson-Fabry disease","volume":"122","author":"Meroni","year":"1997","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1016\/j.neurol.2011.03.013_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neurol.2011.03.013_bib0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","article-title":"White matter lesions in Fabry disease occur in prior selectively hypometabolic and hyperperfused brain regions","volume":"62","author":"Moore","year":"2003","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.neurol.2011.03.013_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","article-title":"Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry disease treatment centre","volume":"33","author":"Nguyen","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"issue":"2","key":"10.1016\/j.neurol.2011.03.013_bib0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry outcome survey","volume":"157","author":"Orteu","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.neurol.2011.03.013_bib0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","article-title":"Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder","volume":"53","author":"Samiy","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.neurol.2011.03.013_bib0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease","volume":"28","author":"Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurol.2011.03.013_bib0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mus.20550","article-title":"Enzyme replacement therapy and intraepidermal innervation density in Fabry disease","volume":"34","author":"Schiffmann","year":"2006","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.neurol.2011.03.013_bib0110","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neurol.2011.03.013_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.neurol.2011.03.013_bib0120","first-page":"916","article-title":"T1\u00a0hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease","volume":"24","author":"Takanashi","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.neurol.2011.03.013_bib0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T14:11:50Z","timestamp":1639663910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0035378711003584"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.03.013","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}